AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2022
Oct 3, 2022
35475_dirs_2022-10-03_979a0860-c43c-4c8b-9bca-3b29f1e01235.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2022-09-30
Reporting Person: Karah Hila (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | Stock Option (right to buy) | $2.16 | A | 13750 | Acquired | 2032-09-30 | Common Stock (13750) | Direct |
Footnotes
F1: The stock option vests and becomes exercisable on September 30, 2023.
More from Indaptus Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12
Director's Dealing
2026
Jan 23